| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Brain drug targeting: a computational approach for overcoming blood–brain barrier
|
Mehdipour, Ahmad Reza
|
|
2009
|
14 |
21-22 |
p. 1030-1036
7 p.
|
artikel
|
| 2 |
Contents
|
|
|
2009
|
14 |
21-22 |
p. i-
1 p.
|
artikel
|
| 3 |
Contents
|
|
|
2009
|
14 |
21-22 |
p. iii-
1 p.
|
artikel
|
| 4 |
Dihydropyridines: evaluation of their current and future pharmacological applications
|
Edraki, Najmeh
|
|
2009
|
14 |
21-22 |
p. 1058-1066
9 p.
|
artikel
|
| 5 |
Drug discovery dilemma and Cura Quartet collaboration
|
Shah, Salim
|
|
2009
|
14 |
21-22 |
p. 1006-1010
5 p.
|
artikel
|
| 6 |
Groundbreaking gold(III) anticancer agents
|
Aldinucci, Donatella
|
|
2009
|
14 |
21-22 |
p. 1075-1076
2 p.
|
artikel
|
| 7 |
NMR methods in fragment screening: theory and a comparison with other biophysical techniques
|
Dalvit, Claudio
|
|
2009
|
14 |
21-22 |
p. 1051-1057
7 p.
|
artikel
|
| 8 |
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
|
Bansal, Tripta
|
|
2009
|
14 |
21-22 |
p. 1067-1074
8 p.
|
artikel
|
| 9 |
Open Innovation: share or die…
|
Talaga, Patrice
|
|
2009
|
14 |
21-22 |
p. 1003-1005
3 p.
|
artikel
|
| 10 |
Revealing promiscuous drug–target interactions by chemical proteomics
|
Bantscheff, Marcus
|
|
2009
|
14 |
21-22 |
p. 1021-1029
9 p.
|
artikel
|
| 11 |
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow
|
Pors, Klaus
|
|
2009
|
14 |
21-22 |
p. 1045-1050
6 p.
|
artikel
|
| 12 |
The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?
|
Ritchie, Timothy J.
|
|
2009
|
14 |
21-22 |
p. 1011-1020
10 p.
|
artikel
|
| 13 |
Will biomedical innovation change the future of healthcare?
|
Schmid, Esther F.
|
|
2009
|
14 |
21-22 |
p. 1037-1044
8 p.
|
artikel
|
Tijdschrift beschrijving